October 5, 2011—Accuray Incorporated announced it is unveiling several enhancements to its CyberKnife Robotic Radiosurgery System and TomoTherapy Radiation Therapy System at the American Society for Radiation Oncology (ASTRO) 53rd annual meeting. The company is also rolling out its Diamond Plus Service Program to TomoTherapy customers. ASTRO 2011 takes place Oct. 2-6 at the Miami Beach Convention Center in Miami, Fla.

In emergency and trauma medicine, the “golden hour” refers to the time during which medical/surgical intervention has the greatest likelihood of saving a life. The shorter the time to intervention following a severe injury, the greater the chance of survival. Computed tomography (CT) is integral to these patients’ assessment, diagnosis and treatment planning.

October 4, 2011 – Etiam will debut version 3.20 of its Secure Medical Networking system at RSNA 2011. It supports unified film, CD and electronic data transfer and now fully integrates imaging information from beyond the enterprise into existing hospital workflow.

October 4, 2011 — GE Healthcare will demonstrate its latest technologies and advancements across all product lines at RSNA 2011.

October 4, 2011 — peerVue will debut enhancements to its Qualitative Intelligence and Communications System (QICS) at RSNA 2011. QICS is the company’s novel Web-based platform that transforms existing healthcare data into qualitative intelligence used to improve workflows.

October 4, 2011 — SourceCorp will introduce a new managed medical image storage service at RSNA 2011. The company’s new multi-tiered, vendor neutral storage solution stores all data in multiple ultra-secure Tier IV data centers in geographically dispersed locations.

 

October 4, 2011 — Viztek will display the newest features of its Opal-RAD picture archiving and communication system (PACS) at RSNA 2011.

October 4, 2011 – The International Contrast Ultrasound Society (ICUS) submitted a petition this week to the U.S. Food and Drug Administration (FDA) requesting removal of the boxed warnings on ultrasound contrast agents. The members of the group say this would bring the product labeling into line with the current body of scientific research, which it says clearly demonstrates the safety and clinical benefits of these imaging products.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now